https://www.selleckchem.com/products/VX-745.html
The COVID-19 pandemic and the subsequent effects on healthcare systems is having a significant effect on the management of long-term autoimmune conditions. The aim of this study was to assess the problems faced by patients with idiopathic inflammatory myopathies (IIM). An anonymized eSurvey was carried out with a focus on effects on disease control, continuity of medical care, drug procurance and prevalent fears in the patient population. Of the 608 participants (81.1% female, median (s.d.) age 57 (13.9) years), dermatomyositis was the
Like
Comment
Share
